No single molecular target

The designation "No single molecular target" is used in pharmacology to describe therapeutic agents that do not exert their primary effect through a specific interaction with a single protein, nucleic acid, or other discrete molecular structure (StatPearls, 2023). This category includes drugs that act via non-specific chemical or physical means, such as antacids that neutralize gastric acid or osmotic laxatives like polyethylene glycol that draw water into the intestinal lumen (Merck Manual, 2024). It also encompasses complex mixtures, such as certain botanical extracts or traditional medicines, where the therapeutic outcome is the result of synergistic effects across multiple pathways (NIH, 2022). In some cases, this term is applied to "dirty drugs" that exhibit high levels of polypharmacology, interacting with a wide array of receptors and enzymes simultaneously. For biotech analysts, this classification indicates a high degree of mechanistic complexity and potential difficulties in defining precise safety and efficacy profiles during drug development. Consequently, these agents often require broader toxicological screening and may face unique regulatory hurdles due to the lack of a defined molecular pathway.

Other names

Non-specific mechanism of actionUnknown targetMulti-target mechanismPolypharmacologyNon-receptor mediated action

The mechanism of action involves non-specific physical, chemical, or osmotic interactions, or broad polypharmacological effects across multiple systems rather than binding to a single discrete molecular entity.